LDS/Medical Tests/p16 by Immunohistochemistry (CINtec® and CINtec® PLUS Cytology)

p16 by Immunohistochemistry (CINtec® and CINtec® PLUS Cytology)

The CINtec® Histology and CINtec® PLUS Cytology assays are complementary, qualitative immunoassays designed to provide objective biomarker information for the diagnosis and management of cervical precancer and cancer. Both assays detect p16ᴵᴺᴷ⁴ᵃ, a cyclin-dependent kinase inhibitor and established biomarker of transforming high-risk HPV infection but are applied to different specimen types and clinical settings to improve diagnostic accuracy and reproducibility.

CINtec Histology is an immunohistochemistry (IHC) test performed on formalin-fixed, paraffin-embedded (FFPE) cervical biopsy specimens. It employs a monoclonal anti-p16 antibody (clone E6H4) optimized for use on the VENTANA BenchMark ULTRA platform with OptiView DAB detection. The test serves as an adjunct to H&E evaluation to improve interobserver consistency among pathologists. Overexpression of p16 occurs as a surrogate event when retinoblastoma protein (pRb) is inactivated by the E7 oncoprotein of high-risk HPV, disrupting cell cycle regulation and driving abnormal proliferation. Thus, strong, diffuse nuclear and cytoplasmic p16 staining identifies cells undergoing HPV-mediated oncogenic transformation.

CINtec PLUS Cytology is an immunocytochemistry (ICC) dual-stain assay for liquid-based cytology specimens collected in ThinPrep® PreservCyt® solution. It simultaneously detects p16ᴵᴺᴷ⁴ᵃ (cytoplasmic brown stain) and Ki-67 (nuclear red stain) within the same cell. Under normal conditions, these proteins are not co-expressed; however, in HPV-transformed cells, deregulation of the E6/E7 pathway leads to co-localization of both markers, signifying aberrant cell cycle activation. Detection of even a single dual-stained cell is considered positive, identifying women at highest risk for CIN2+ lesions who may benefit from immediate colposcopic evaluation. The test is approved as a triage assay for women aged 25-65 years who are HPV-positive (either HPV16/18 or other high-risk genotypes) or who have discrepant cytology/HPV results (e.g., NILM cytology with high-risk HPV+) to determine need for immediate colposcopy versus routine follow-up.

Both assays enhance diagnostic precision by providing morphology-independent biomarkers that distinguish reactive atypia from true precancerous transformation. Their combined use improves clinical management by refining triage algorithms for HPV-positive women and standardizing pathologic interpretation of cervical biopsies.

  • As an aid in the diagnosis and management of cervical cancer
  • Triage testing following HPV primary screening for HPV positive results in women ages 25-65
  • Reflex testing following discrepant co-testing results in women ages 30-65
Assay Result Interpretation
CINtec Histology Positive – Diffuse, strong nuclear and cytoplasmic staining of dysplastic epithelial cells. Indicates HPV-related transforming infection consistent with CIN2+ lesion.
  Negative – Absent or focal staining. Suggests non-transforming HPV infection or benign/reactive process.
CINtec PLUS Cytology Positive – One or more epithelial cells showing simultaneous brown cytoplasmic (p16) and red nuclear (Ki-67) staining. Indicative of HPV-transformed cells; high risk for CIN2+.
  Negative – No cells co-expressing p16 and Ki-67; single-marker staining not diagnostic. Suggests absence of transforming HPV infection.
  • CINtec Histology: Absent of focal staining
  • CINtec PLUS Cytology: Negative for co-expression of p16 and Ki-67
CINtec® Histology: IHC on formalin-fixed, paraffin-embedded cervical tissue; p16 expression detected using monoclonal antibodies and chromogenic detection. CINtec® PLUS Cytology: Immunocytochemistry on liquid-based cytology specimens; dual-stain detection of p16 and Ki-67 using chromogenic substrates.

CINtec Histology: Formalin-fixed, paraffin-embedded (FFPE) tissue.

CINtec PLUS Cytology: Cervical specimens collected in ThinPrep® PreservCyt® Solution.

Stability

FFPE tissue is stable in room temperature for longer time

ThinPrep is stable at room temperature for 30 days.

PAP smear, HPV DNA, HPV genotyping, Liquid-based cytology (LBC), Ki-67 proliferation marker, cervical biopsy, CBC, comprehensive metabolic panel, CEA, E6 and E7 gene expression detection assay for cervical cancer.
1 to 3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Am J Clin Pathol. 2012 Nov;138(5):652-6. [PMID: 23086765]
  • Rom J Morphol Embryol. 2024 Jan-Mar;65(1):99-105. [PMID: 38527989]
  • J Cytol. 2021 Apr-Jun;38(2):94-100. [PMID: 34321776]
  • Cancer Cytopathol. 2022 Dec;130(12):983-992. [PMID: 35976043]
  • Arch Pathol Lab Med. 2020 Jun;144(6):725-734. [PMID: 31718233]
  • Roche Diagnostics. CINtec PLUS Cytology, Product Information. [Accessed 2025]
  • Roche Diagnostics. Package Insert CINtec PLUS Cytology. Rev E. 2025.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login